Catalent Announces Opening of its New Global Corporate Headquarters in Tampa, Florida

Relocation reflects a strategic expansion in Florida alongside long-standing manufacturing facility in nearby St. Petersburg

New headquarters designed to support innovation, collaboration and growth

September 22, 2025 - TAMPA, Fla. - Catalent, Inc., the leader in enabling the development and supply of better treatments for patients worldwide, today announced the opening of its new global corporate headquarters in Tampa, Fla. The state-of-the-art site has been designed to foster innovation, collaboration and growth, supporting the Company's commitment to driving value for its pharmaceutical, biotech and consumer health customers through the highest level of service excellence and a Patient First mindset.

Earlier this year Catalent announced it would relocate from its previous headquarters in Somerset, N.J. and open a corporate office in Bridgewater, N.J. and a new corporate headquarters in Tampa. The move to Tampa reflects a strategic expansion in Florida, where the Company has a long-standing presence through its 500,000 square foot site in St. Petersburg, which has more than 630 employees and serves as the Company's primary softgel development and manufacturing facility in North America.

"The opening of our new global headquarters in Tampa is an important milestone that reflects our aspirations for continued growth and recognizes our heritage as an organization built on innovation, service excellence and integrity," said Alessandro Maselli, President & Chief Executive Officer of Catalent. "For nearly half a century, we have enjoyed a presence in the Tampa region where today we provide services ranging from early phase development to full-scale commercial manufacturing at our St. Petersburg site. We are excited to expand our presence in the region."

Catalent will host a ribbon cutting event today to commemorate its new global corporate headquarters. The event will be attended by Catalent executives and state and local officials, including J. Alex Kelly, Secretary of the Florida Department of Commerce; Jane Castor, Mayor of the City of Tampa; Craig Richard, President & CEO of the Tampa Bay Economic Development Council; and Mike Swesey, President & CEO of the St. Petersburg Economic Development Corp.

Catalent's new global corporate headquarters is located on the 41^st floor of Bank of America Plaza, a 42-story Class "A" office tower located in the heart of Tampa's Central Business District at 101 East Kennedy Boulevard, Tampa, Florida 33602.

REACTIONS FROM STATE AND LOCAL OFFICIALS

J. Alex Kelly, Secretary of the Florida Department of Commerce

"On behalf of FloridaCommerce, congratulations to Catalent and the entire Tampa Bay region for Catalent's new global corporate headquarters in Tampa," said Florida Secretary of Commerce, J. Alex Kelly. "Thanks to the Governor's leadership, with a strong focus on research and development, nine consecutive years as the #1 state for postsecondary education, and three consecutive years as the #1 state for talent development, Florida has become #2 in the nation for both pharmaceutical and medical device manufacturing. We're grateful that Catalent's existing operations have been a part of that journey, and this increased investment is going to help propel Tampa Bay and Florida to an even greater leadership position in elevating people's health and quality of life."

Jane Castor, Mayor of the City of Tampa

"Tampa continues to be an ideal location for innovative companies and we are excited to welcome the Catalent team to our community," said Jane Castor, Mayor of the City of Tampa. "Tampa is perfect for an innovative life sciences company like Catalent, thanks to our skilled talent, academic institutions, local economic development organizations and strategic location. We are excited to support the company's growth here."

Craig Richard, President & CEO of the Tampa Bay Economic Development Council

"We're delighted to join Catalent in celebrating the opening of its new headquarters in the heart of the Tampa Medical and Research District," said Craig J. Richard, President and CEO of Tampa Bay Economic Development Council. "Catalent's success with its manufacturing operations in Pinellas County and its further commitment to the Tampa Bay region is proof that this market has the talent to power the growth of global life sciences companies. We look forward to assisting Catalent as they expand their operations on both sides of the bay."

Mike Swesey, President & CEO of the St. Petersburg Economic Development Corp.

"Catalent's 45-year history of growth and investment in its St. Petersburg facility and employees have been an important driver of our local economy, and we are excited that the Company is moving its corporate headquarters just across the bay in Tampa," said Mike Swesey, President & CEO of the St. Petersburg Economic Development Corp. "Their relocation is a testament to our business-friendly location and warm, inclusive community, highlighting our belief that more and more global companies will choose our region as a strategic location for their corporate offices and/or innovation hubs."

ABOUT CATALENT

Catalent, Inc. is a leading global contract development and manufacturing organization (CDMO) whose mission is to develop, manufacture, and supply products that help people live better and healthier lives. Catalent is dedicated to delivering unparalleled service to pharma, biotech, and consumer health customers, supporting product development, launch, and full life-cycle supply. With time-tested experience in development sciences, delivery technologies, and multi-modality manufacturing, Catalent supports the acceleration of development programs and the launch of more than a hundred new products every year. Powered by thousands of scientists and technicians and the latest technology platforms at more than 40 global sites, Catalent supplies billions of doses of life-enhancing and life-saving treatments for patients annually. For more information, visit https://www.catalent.com.

CONTACTS

Media Contact:
[email protected]